FIELD: chemistry.
SUBSTANCE: invention relates to a compound used in medicine, said compound having the formula
,
where n – an integer from 1 to 1,500, m is an integer from 1 to 10, each of the units Globo H (Fucα1→2 Galβ1→3 GalNAcβ 1→3 Galα1→4 Galβ1→4 Glc) covalently bonded to the keyhole limpet hemocyanin (KLH) subunit through residues of basic amino acids selected from arginine, lysine, histidine, and combinations thereof, through the depicted linker, wherein the ratio of epitopes to carrier molecules is in the range of 750 to 3,000.
EFFECT: new compounds have been proposed, as well as pharmaceutical compositions based on said compounds, which are effective in the treatment of cancer and the production of monoclonal antibodies for therapeutic or diagnostic purposes.
45 cl, 5 tbl, 8 ex, 33 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS OF IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATES AND USE THEREOF | 2015 |
|
RU2720295C2 |
| THERAPEUTIC ANTIBODIES BINDING TO LEWIS B AND LEWIS Y BIANTENNA ANTIGENS | 2019 |
|
RU2803097C2 |
| CONJUGATES OF ENGINEERED ANTIBODIES WITH CYSTEINE SUBSTITUTES | 2016 |
|
RU2733740C2 |
| IMPROVED THERAPEUTIC INDEX OF INHIBITORS AGAINST IMMUNE CHECKPOINT USING COMBINATION THERAPY INCLUDING PHY906 EXTRACT, SCUTELLARIA BAICALENSIS GEORGI (S) EXTRACT OR COMPOUND OF SUCH EXTRACTS | 2017 |
|
RU2753523C2 |
| LINKER FOR ANTIBODY-DRUG CONJUGATES AND THEIR USE | 2019 |
|
RU2792201C2 |
| CHEMICAL LINKERS AND CONJUGATES THEREOF | 2005 |
|
RU2402548C2 |
| MONOCLONAL ANTIBODY SUPPRESSING THE IMMUNOSUPPRESSIVE FUNCTIONS OF PATHOGENS, ANTIGEN-BINDING FRAGMENT OF THE SPECIFIED ANTIBODY AND HYBRIDOMAS PRODUCING THE SPECIFIED ANTIBODY | 2017 |
|
RU2751918C2 |
| HUMAN INTERLEUKIN-2 VARIANT OR ITS DERIVATIVE | 2019 |
|
RU2799437C2 |
| ANTIBODY-DRUG CONJUGATES BASED ON ERIBULIN AND APPLICATION METHODS | 2017 |
|
RU2754369C2 |
| COVALENT LINKERS IN ANTIBODY-DRUG CONJUGATES, METHODS FOR PREPARING THEM AND USE THEREOF | 2016 |
|
RU2698727C1 |
